LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound
Primary Purpose
Dehydration in Children, Dehydration
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
LifeFlow
Sponsored by
About this trial
This is an interventional health services research trial for Dehydration in Children
Eligibility Criteria
Inclusion Criteria:
- Female patients older than 1 month and less than 18 years
- Patients require IV crystalloid bolus fluids before a pelvic ultrasound
Exclusion Criteria:
- Known cardiac insufficiency or significant cardiac surgery
- Hepatic insufficiency
- Renal insufficiency
- Any known fluid overload states (ascites, pulmonary edema)
- On any diuretic or antihypertensive therapy
- Known pregnancy
Sites / Locations
- Children's Hospital Los Angeles
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Alaris Pump
LifeFlow
Arm Description
Participants will receive IV fluids delivered by the Alaris IV Pump (standard of care) until their bladder is full.
Participants will receive IV fluids delivered by the LifeFlow Fluid Device until their bladder is full.
Outcomes
Primary Outcome Measures
Duration- Ultrasound Ordered to Completed
The primary outcome variable is the duration (minutes) of time from when the ultrasound was ordered to the completion time of the ultrasound.
Secondary Outcome Measures
Total IV Fluid (mL)
Total IV fluid administered before ultrasound
Duration- Full Bladder
Fluid initiation and subjective sensation of full bladder
Full Information
NCT ID
NCT03712189
First Posted
October 11, 2018
Last Updated
February 16, 2021
Sponsor
Children's Hospital Los Angeles
Collaborators
410 Medical, Atlanta Pediatric Device Consortium
1. Study Identification
Unique Protocol Identification Number
NCT03712189
Brief Title
LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound
Official Title
The Utility of LifeFlow Rapid Fluid Infuser in Critical and Non-critical Pediatric Patients: a Mixed-method Pilot Study Protocol
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
October 2, 2018 (Actual)
Primary Completion Date
May 31, 2019 (Actual)
Study Completion Date
June 30, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Children's Hospital Los Angeles
Collaborators
410 Medical, Atlanta Pediatric Device Consortium
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is an unblinded, randomized control study examining two fluid delivery modalities for non-critical female patients with a planned transabdominal pelvic ultrasound requiring intravenous fluid boluses.
Detailed Description
Subjects be identified during their clinical course in the ED and will be randomized to either the LifeFlow® fluid delivery or an IV fluid bolus through the Alaris® pump (standard of care). IV fluids will be provided until the subject notes the sensation of a full bladder, at which point, the standard of care clinical practice is to perform the ultrasound. The transabdominal pelvic ultrasound requires a full bladder for optimal visualization of the ovaries, adnexa, and uterus, and is the only alternative to a transvaginal pelvic ultrasound for virginal young women. All other clinical care is per standard of care. The only research component is the randomization and data collection.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dehydration in Children, Dehydration
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Alaris Pump
Arm Type
No Intervention
Arm Description
Participants will receive IV fluids delivered by the Alaris IV Pump (standard of care) until their bladder is full.
Arm Title
LifeFlow
Arm Type
Experimental
Arm Description
Participants will receive IV fluids delivered by the LifeFlow Fluid Device until their bladder is full.
Intervention Type
Device
Intervention Name(s)
LifeFlow
Intervention Description
The LifeFlow® is a hand-operated rapid infuser designed to administer fluids to patients by a single user, for clinical situations in which a large volume or rapid infusion of fluid or colloid is required. The device delivers fluid in 10mL increments with each complete handle compression, which refills during release, automating a push-pull mechanism. The syringe then automatically refills with handle release.
Primary Outcome Measure Information:
Title
Duration- Ultrasound Ordered to Completed
Description
The primary outcome variable is the duration (minutes) of time from when the ultrasound was ordered to the completion time of the ultrasound.
Time Frame
From ED (Emergency Department) arrival to discharge/admission, less than 12 hours
Secondary Outcome Measure Information:
Title
Total IV Fluid (mL)
Description
Total IV fluid administered before ultrasound
Time Frame
From ED arrival to discharge/admission, less than 12 hours
Title
Duration- Full Bladder
Description
Fluid initiation and subjective sensation of full bladder
Time Frame
From ED arrival to discharge/admission, less than 12 hours
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
1 Month
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Female patients older than 1 month and less than 18 years
Patients require IV crystalloid bolus fluids before a pelvic ultrasound
Exclusion Criteria:
Known cardiac insufficiency or significant cardiac surgery
Hepatic insufficiency
Renal insufficiency
Any known fluid overload states (ascites, pulmonary edema)
On any diuretic or antihypertensive therapy
Known pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Todd P Chang, MD
Organizational Affiliation
Children's Hospital Los Angeles
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ara Festekjian, MD
Organizational Affiliation
Children's Hospital Los Angeles
Official's Role
Study Director
Facility Information:
Facility Name
Children's Hospital Los Angeles
City
Los Angeles
State/Province
California
ZIP/Postal Code
90026
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
30106868
Citation
Kline M, Crispino L, Bhatnagar A, Panchal RA, Auerbach M. A Randomized Single-Blinded Simulation-Based Trial of a Novel Method for Fluid Administration to a Septic Infant. Pediatr Emerg Care. 2021 Jun 1;37(6):e313-e318. doi: 10.1097/PEC.0000000000001583.
Results Reference
background
Learn more about this trial
LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound
We'll reach out to this number within 24 hrs